- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Frank James on the Role of Stigma in Addiction Treatment
It is important to treat addiction as a chronic disease and to address the stigmatization of both the addiction and the treatments we have available to treat it, said Dr Frank James, MD, JD, of American Society of Addiction Medicine.
Transcript
What is the role of stigma and how does it prevent people from getting treatment?
One aspect of approaching this epidemic is getting rid of the stigmatization of addiction and opioid addiction. It’s important to realize that people that have an opioid addiction, it’s not a moral problem or a problem of not wanting to get better or stay clean and sober. It is a chemical process in the brain. It can be treated with medication assistant treatments. Anyone can be addicted to an opioid. It can be your neighbor, your teacher. It crosses all socioeconomic barriers, and so once we approach it as a chronic disease and realize that there are treatments for this, then the stigma about having addiction goes away. So, we really need to address the stigmatization of both the addiction and the stigmatization of the treatments we have that are available to help people with this problem.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
